tiprankstipranks
Trending News
More News >
Mani, Inc. (JP:7730)
:7730
Japanese Market
Advertisement

Mani, Inc. (7730) AI Stock Analysis

Compare
0 Followers

Top Page

JP:7730

Mani, Inc.

(7730)

Rating:72Outperform
Price Target:
¥1,355.00
▲(5.78%Upside)
Mani, Inc. scores well due to strong financial performance and moderate valuation. The technical analysis suggests mixed signals, with short-term bullish trends but longer-term caution. The absence of earnings call data limits insights into future guidance.

Mani, Inc. (7730) vs. iShares MSCI Japan ETF (EWJ)

Mani, Inc. Business Overview & Revenue Model

Company DescriptionMani, Inc. (7730) is a Japanese company specializing in the manufacturing and sale of precision instruments and medical devices. The company is primarily involved in the dental and surgical instrument sectors, providing high-quality products used in medical procedures globally. Mani, Inc. is recognized for its innovative and reliable solutions that cater to the needs of healthcare professionals, ensuring optimal performance and safety.
How the Company Makes MoneyMani, Inc. generates revenue through the sale of its precision instruments and medical devices to healthcare providers, dental practitioners, and hospitals. The company's revenue streams are primarily driven by its extensive product portfolio, which includes dental instruments like files and reamers, as well as surgical instruments such as needles and sutures. Mani, Inc. benefits from a strong global distribution network and partnerships with medical distributors, enabling it to reach a wide customer base. Additionally, the company invests in research and development to maintain its competitive edge and meet the evolving demands of the medical industry, thereby ensuring a steady flow of income from its innovative product offerings.

Mani, Inc. Financial Statement Overview

Summary
Mani, Inc. exhibits strong financial performance with increasing revenue, robust profit margins, and a stable balance sheet. However, cash flow shows volatility due to high capital expenditures, which slightly lowers the score.
Income Statement
90
Very Positive
Mani, Inc. demonstrates strong financial performance with a consistent increase in revenue from 2020 to 2024. The gross profit margin has remained robust, reflecting efficient cost management. Net profit margin has improved, indicating enhanced profitability. Notably, the EBIT and EBITDA margins have shown positive trends, underscoring operational efficiency.
Balance Sheet
85
Very Positive
The balance sheet of Mani, Inc. reflects financial stability with a low debt-to-equity ratio, indicating conservative leverage. The return on equity is strong, showcasing effective use of shareholders' equity to generate profits. A high equity ratio further illustrates the company's solid financial foundation.
Cash Flow
75
Positive
Mani, Inc. displays a mixed cash flow performance. While operating cash flow is healthy, free cash flow has shown volatility due to significant capital expenditures in recent years. The free cash flow to net income ratio is low, suggesting potential constraints in cash availability for strategic investments.
BreakdownSep 2024Sep 2023Sep 2022Sep 2021Sep 2020
Income Statement
Total Revenue28.51B24.49B20.42B17.19B15.20B
Gross Profit17.90B15.42B12.57B11.01B9.88B
EBITDA10.70B9.94B9.17B7.55B6.26B
Net Income6.29B5.95B5.29B4.29B3.33B
Balance Sheet
Total Assets57.18B54.98B50.11B42.69B39.29B
Cash, Cash Equivalents and Short-Term Investments21.66B25.43B22.73B18.89B17.18B
Total Debt83.00M58.00M117.00M128.00M62.48M
Total Liabilities4.85B5.15B4.70B3.49B2.72B
Stockholders Equity52.33B49.83B45.41B39.20B36.57B
Cash Flow
Free Cash Flow129.00M4.31B4.62B2.52B248.97M
Operating Cash Flow7.81B8.03B6.56B6.38B1.94B
Investing Cash Flow-6.64B-4.02B-2.17B-3.44B-38.33M
Financing Cash Flow-3.70B-3.25B-2.44B-2.23B-2.13B

Mani, Inc. Technical Analysis

Technical Analysis Sentiment
Positive
Last Price1281.00
Price Trends
50DMA
1209.65
Positive
100DMA
1229.36
Positive
200DMA
1442.57
Negative
Market Momentum
MACD
8.32
Negative
RSI
65.03
Neutral
STOCH
70.40
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:7730, the sentiment is Positive. The current price of 1281 is above the 20-day moving average (MA) of 1224.20, above the 50-day MA of 1209.65, and below the 200-day MA of 1442.57, indicating a neutral trend. The MACD of 8.32 indicates Negative momentum. The RSI at 65.03 is Neutral, neither overbought nor oversold. The STOCH value of 70.40 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:7730.

Mani, Inc. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (65)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
77
Outperform
¥139.14B16.186.55%3.78%2.42%-13.12%
73
Outperform
€167.63B29.314.78%2.64%20.53%-75.16%
72
Outperform
¥127.83B23.42
3.08%5.82%-20.09%
72
Outperform
$643.35B59.977.09%1.02%17.38%-30.54%
69
Neutral
€89.54B15.906.62%2.39%4.56%24.10%
65
Neutral
¥355.44B11.35-2.99%2.49%11.76%-10.21%
61
Neutral
¥72.90B16.81
2.42%15.55%42.14%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JP:7730
Mani, Inc.
1,265.50
-822.90
-39.40%
JP:7979
Shofu Inc.
2,021.00
-343.58
-14.53%
JP:7716
Nakanishi
1,973.00
-580.60
-22.74%
JP:7780
Menicon Co
1,171.00
-200.70
-14.63%
JP:7747
Asahi Intecc Co
2,400.50
67.58
2.90%
JP:7817
Paramount Bed Holdings Co
2,566.00
9.92
0.39%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jul 19, 2025